NCT00205712View on ClinicalTrials.gov

Prevention of N-methyl-D-aspartate (NMDA) Antagonist-induced Psychosis in Kids

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Psychoses, Substance-Induced
Interventions
DRUG

Ketamine

Ketamine without dexmedetomidine

DRUG

Dexmedetomidine

Ketamine plus dexmedetomidine

Trial Locations (1)

63110

Washington University School of Medicine, Psychiatry Dept., St Louis

All Listed Sponsors
collaborator

National Alliance for Research on Schizophrenia and Depression

OTHER

lead

Washington University School of Medicine

OTHER

NCT00205712 - Prevention of N-methyl-D-aspartate (NMDA) Antagonist-induced Psychosis in Kids | Biotech Hunter | Biotech Hunter